Sclerosing keratitis is a peripheral corneal opacification that develops next to an area of active scleritis.

The affected stroma turns gray-white, so the limbus seems to creep onto the cornea, and clinicians also call the condition sclerokeratitis. Because it often accompanies severe or vasculitic scleritis, it calls for a systemic workup.


What Sclerosing Keratitis Is

The term describes stromal inflammation and scarring adjacent to inflamed sclera, and over time the clear peripheral cornea takes on the opaque look of sclera. Usually the epithelium stays intact and stromal thickness is preserved, so the lesion reflects scarring, while active melting is absent.

Why the Cornea Opacifies

The peripheral cornea shares blood supply and immune cells with the limbus and sclera. As a result, scleral inflammation spreads into the neighboring stroma. Inflammatory mediators and new vessels then disorganize the collagen lamellae, but the exact mechanism is not fully defined and likely varies with the underlying disease.

Test your knowledge 10 questions from this article
Choroida · Slit-lamp imaging

All-fit Slit-Lamp Adapter

Record and share exactly what you see at the slit lamp. One adapter fits any slit lamp or surgical microscope — and any smartphone.

From Choroida — the team behind this site

Slit Lamp Signs of Sclerosing Keratitis

  • Gray-white stromal opacity contiguous with inflamed sclera
  • Tongue or crescent shape advancing toward the center
  • Intact epithelium with little or no fluorescein staining
  • Normal or near-normal stromal thickness
  • Vessels entering the opacity, with lipid at the edge in chronic cases

What the Patient Reports

Most patients present with the pain of scleritis, which feels deep and boring, and the ache often wakes them at night and radiates to the brow or jaw. In addition, redness and globe tenderness are common, while vision stays normal unless the opacity reaches the visual axis or induces astigmatism.

The Scleritis Behind It

Sclerosing keratitis accompanies anterior scleritis, often of the nodular or necrotizing type, and some cases also follow diffuse disease that smolders for months. Therefore, classify the scleritis first, because the pattern guides the workup (see scleritis classification).

Systemic Associations of Sclerosing Keratitis

Rheumatoid arthritis is the classic association in older patients, while granulomatosis with polyangiitis and relapsing polychondritis also appear in reported series. In addition, herpes zoster ophthalmicus can produce scleritis with adjacent corneal scarring, and syphilis and tuberculosis are less common, yet treatable, causes.

Sclerosing Keratitis Versus PUK

Peripheral ulcerative keratitis shows an epithelial defect and progressive stromal thinning, whereas sclerosing keratitis keeps an intact surface and stable thickness. PUK can perforate quickly while the sclerosing form scars slowly, but both share the same systemic triggers and can coexist in one eye (see peripheral ulcerative keratitis).

Distinguishing Interstitial Keratitis

Interstitial keratitis involves the deep stroma, often centrally or diffusely, with ghost vessels, and it usually lacks a contiguous zone of active scleritis. For example, syphilitic disease leaves bilateral deep scars long after the acute phase (see interstitial keratitis), so location and continuity with sclera help separate the two.

Sclerosing Keratitis (Sclerokeratitis): Signs and Causes

Other Look-Alikes

  • Arcus senilis, which keeps a clear lucid interval at the limbus
  • Terrien marginal degeneration, with thinning and lipid but little pain
  • A healed infectious scar in the peripheral cornea

Workup for Sclerosing Keratitis

First, take a full systemic history, including joint, sinus, ear, lung and kidney symptoms, and then order a blood count, ESR, CRP, rheumatoid factor, anti-CCP and ANCA. Also request treponemal serology, urinalysis and a chest radiograph, and finally ask about prior shingles in the same dermatome.

Treating Sclerosing Keratitis

Treatment targets the scleritis, because the corneal change follows it, and oral NSAIDs may control mild nodular disease. However, necrotizing or vasculitic scleritis needs systemic corticosteroids and usually a steroid-sparing immunosuppressive agent, so co-manage with a rheumatologist, since these drugs carry significant risks.

Role of Topical Steroids

Topical corticosteroids can calm adjacent corneal inflammation, but they cannot control scleritis on their own. They also raise intraocular pressure and may worsen thinning if melting begins, so use them only as adjuncts with close monitoring.

What Treatment Cannot Do

Established opacity rarely clears completely, even after the scleritis becomes quiet. Some peripheral lucency may return as vessels regress, and central encroachment may later require keratoplasty.

Counseling the Patient

Explain that the white patch reflects inflammation in the wall of the eye, and mention that the same process may affect joints, kidneys or lungs. Ask patients to report new pain, redness or blurred vision quickly, and because adherence drives outcome, discuss drug side effects openly.

Follow-Up in Sclerosing Keratitis

Review active cases every one to two weeks until the scleritis settles, and at each visit stain the cornea and check thickness at the leading edge. Anterior segment OCT helps document early thinning, and any new epithelial defect suggests conversion toward ulceration, so intensify systemic therapy promptly.

Pitfalls to Avoid

  • Do not treat the opacity as an isolated scar
  • Never skip ANCA testing in painful necrotizing scleritis
  • Do not rely on topical steroids for scleritis control
  • Remember herpes zoster as a possible cause

All-fit smartphone adapter on a slit lampFundus Explorer Pro smartphone fundus camera
Choroida · Clinical imaging

Document what you see

Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.

From Choroida — the team behind this site

References

  1. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163-191.
  2. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102:687-692.
  3. Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol. 2005;50:351-363.
  4. Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33:835-854.

Test yourself

A few questions straight from this article.

1 / 10 0 correct
  1. How is sclerosing keratitis defined?

Ahmed Ophthalmologist

Writes and reviews the clinical articles on Educate. Every post is checked against peer-reviewed sources before it goes live.